» Articles » PMID: 8764064

African Green Monkey Kidney (Vero) Cells Provide an Alternative Host Cell System for Influenza A and B Viruses

Overview
Journal J Virol
Date 1996 Aug 1
PMID 8764064
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The preparation of live, attenuated human influenza virus vaccines and of large quantities of inactivated vaccines after the emergence or reemergence of a pandemic influenza virus will require an alternative host cell system, because embryonated chicken eggs will likely be insufficient and suboptimal. Preliminary studies indicated that an African green monkey kidney cell line (Vero) is a suitable system for the primary isolation and cultivation of influenza A viruses (E. A. Govorkova, N. V. Kaverin, L. V. Gubareva, B. Meignier, and R. G. Webster, J. Infect. Dis. 172:250-253, 1995). We now demonstrate for the first time that Vero cells are suitable for isolation and productive replication of influenza B viruses and determine the biological and genetic properties of both influenza A and B viruses in Vero cells; additionally, we characterize the receptors on Vero cells compared with those on Madin-Darby canine kidney (MDCK) cells. Sequence analysis indicated that the hemagglutinin of Vero cell-derived influenza B viruses was identical to that of MDCK-grown counterparts but differed from that of egg-grown viruses at amino acid positions 196 to 198. Fluorescence-activated cell sorting analysis showed that although Vero cells possess predominantly alpha2,3 galactose-linked sialic acid, they are fully susceptible to infection with either human influenza A or B viruses. Moreover, all virus-specific polypeptides were synthesized in the same proportions in Vero cells as in MDCK cells. Electron microscopic and immunofluorescence studies confirmed that infected Vero cells undergo the same morphological changes as do other polarized epithelia] cells. Taken together, these results indicate that Vero cell lines could serve as an alternative host system for the cultivation of influenza A and B viruses, providing adequate quantities of either virus to meet the vaccine requirements imposed by an emerging pandemic.

Citing Articles

Generation of a VeroE6 Pgp gene knock out cell line and its use in SARS-CoV-2 antiviral study.

Zhu Y, Binder J, Yurgelonis I, Rai D, Lazarro S, Costales C Antiviral Res. 2022; 208:105429.

PMID: 36208677 PMC: 9533647. DOI: 10.1016/j.antiviral.2022.105429.


Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques.

Chua B, Sekiya T, Koutsakos M, Nomura N, Rowntree L, Nguyen T PLoS Pathog. 2022; 18(10):e1010891.

PMID: 36206307 PMC: 9581423. DOI: 10.1371/journal.ppat.1010891.


Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19.

Loh D, Reiter R Int J Mol Sci. 2022; 23(15).

PMID: 35897696 PMC: 9368024. DOI: 10.3390/ijms23158122.


The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.

Oishi K, Horiuchi S, Minkoff J, tenOever B J Virol. 2022; 96(15):e0076522.

PMID: 35862681 PMC: 9364782. DOI: 10.1128/jvi.00765-22.


Hydroxychloroquine Does Not Function as a Direct Zinc Ionophore.

Kavanagh O, Bhattacharya S, Marchetti L, Elmes R, OSullivan F, Farragher J Pharmaceutics. 2022; 14(5).

PMID: 35631485 PMC: 9147311. DOI: 10.3390/pharmaceutics14050899.


References
1.
Monto A, Maassab H, BRYAN E . Relative efficacy of embryonated eggs and cell culture for isolation of contemporary influenza viruses. J Clin Microbiol. 1981; 13(1):233-5. PMC: 273760. DOI: 10.1128/jcm.13.1.233-235.1981. View

2.
Lau S, Scholtissek C . Abortive infection of Vero cells by an influenza A virus (FPV). Virology. 1995; 212(1):225-31. DOI: 10.1006/viro.1995.1473. View

3.
Nakamura K, Homma M . Protein synthesis in Vero cells abortively infected with influenza B virus. J Gen Virol. 1981; 56(Pt 1):199-202. DOI: 10.1099/0022-1317-56-1-199. View

4.
Schild G, Oxford J, de Jong J, Webster R . Evidence for host-cell selection of influenza virus antigenic variants. Nature. 1983; 303(5919):706-9. DOI: 10.1038/303706a0. View

5.
Rogers G, Paulson J . Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology. 1983; 127(2):361-73. DOI: 10.1016/0042-6822(83)90150-2. View